Orchestra BioMed Stock Forum

$Orchestra BioMed (OBIO.US)$
Breakthrough Heart Failure Prevention: New Clinical Data Reveals Orchestra BioMed's AVIM Therapy Tackles Root Cause

$Orchestra BioMed (OBIO.US)$
Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference
Wednesday, 12th February at 10:43 am
• Late-breaking oral presentation features echocardiographic data analysis showing favorable impact of AVIM therapy on MODERATO II study patients with diastolic dysfunction, a key component in the development of ...

$Orchestra BioMed (OBIO.US)$
Orchestra BioMed Announces Further Details on In-Person R&D Day in New York Featuring Key Opinion Leaders to Discuss AVIM Therapy Program in Hypertensive Pacemaker Patients on June 11, 2024

$Orchestra BioMed (OBIO.US)$ Held up fairly nice!

$Orchestra BioMed (OBIO.US)$ The FDA Granted An Investigational Device Exemption To Initiate BACKBEAT Study Evaluating Orchestra Biomed's Atrioventricular Interval Modulation Therapy (BACKBEAT CNT) For Hypertensive Patients Who Are Indicated For A Dual-chamber Cardiac Pacemaker

$Orchestra BioMed (OBIO.US)$ another difficult day,